Skip to main content
. 2014 Jan 24;9:23. doi: 10.1186/1746-1596-9-23

Figure 1.

Figure 1

Serum CXCL16 increased in active nephrotic syndrome. p < 0.05() vs Control; p < 0.05() vs Remissive NS.